| Neoprobe Corporation is focused on developing and commercializing innovative biomedical products that meet the critical intraoperative, diagnostic and therapeutic treatment needs of patients and physicians. Our primary area of focus is in improving cancer surgery outcomes by using our market-leading gamma detection devices in combination with radiopharmaceutical agents also referred to as “tracing” or “targeting” agents. |
